THC Valuation

Add to Watchlist

Advanced Chart

0.000

0.000(0.000%)

Overview
Forecast
Valuation

THC Relative Valuation

THC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, THC is overvalued; if below, it's undervalued.

Historical Valuation

Tenet Healthcare Corp (THC) is now in the Fair zone, suggesting that its current forward PE ratio of 11.47 is considered Fairly compared with the five-year average of 13.48. The fair price of Tenet Healthcare Corp (THC) is between 49.05 to 320.58 according to relative valuation methord.

Relative Value

Fair Zone

49.05-320.58

Current Price：148.03

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

3.23

P/B

Median3y

4.67

Median5y

16.17

10.46

FCF Yield

Median3y

11.52

Median5y

25.19

Competitors Valuation Multiple

The average P/S ratio for THC's competitors is 1.26, providing a benchmark for relative valuation. Tenet Healthcare Corp Corp (THC) exhibits a P/S ratio of 0.64, which is -49.15% above the industry average. Given its robust revenue growth of -2.70%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

THC.N

Tenet Healthcare Corp

0.64

Average P/S: 1.26

-2.70%